Are heart failure patients taking their meds? a urine test at the ER aims to find out
NCT ID NCT06459115
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This study investigates whether people with acute decompensated heart failure are taking their prescribed medications as directed. Researchers will test urine samples from 100 patients at the emergency department to directly measure drug levels, and use questionnaires to explore factors like anxiety and depression that may affect adherence. The goal is to understand how often medication non-adherence contributes to heart failure episodes requiring emergency care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If this study finds that many heart failure patients are not taking their medications, it could lead to better support and education to improve adherence and prevent hospital visits.
- What could go wrong
- This is a small, single-center study that only measures adherence at one point in time. It cannot prove whether poor adherence directly caused the heart failure episode.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
100 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients presenting with acute decompensated heart failure (AHF) at the emergency department at Saarland University Medical Center
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age ≥18 years of age * known chronic heart failure irrespective of ejection fraction (heart failure with reduced, mildly reduced, or preserved ejection fraction) * requirement of intravenous diuretics (outpatient or stationary treatment) * stable heart failure medication \>2 weeks * ≥1 sign of volume overload (peripheral edema, jugular venous distension, pulmonary rales, ascites, or demonstration of pulmonary venous congestion on chest X-ray) * elevated natriuretic peptides (N-terminal pro brain natriuretic peptide= nt-pro-BNP ≥125 pg/ml) Exclusion Criteria: \- Not able to give written informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute decompensated heart failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Saarland, Saarland University
Homburg, 66421, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test clues: could two proteins predict heart failure crises?
- Can common heart drugs stay safe during a crisis? a trial investigates
- Heart failure fluid removal device trial halted early
- Massive new registry aims to unlock secrets of deadly heart shock
- Heart failure study aims to tailor treatments using biomarkers
- New device automates fluid removal in heart failure – could it be a game changer?